352820:KRXHYBE Co., Ltd. Analysis
Data as of 2026-06-11 - not real-time
₩218,000.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
HYBE Co., Ltd. is trading well below its 20‑day (223,920) and 50‑day (244,418) simple moving averages, with the 200‑day SMA at 299,420, underscoring a bearish price environment. The RSI sits at 43, indicating neutral momentum, while the MACD line has crossed above its signal line, producing a modest bullish histogram (+174) that suggests a possible short‑term reversal. The stock’s current price of 218,000 is far beneath the DCF‑derived fair value of 416,047, implying an upside of roughly 78% and a strong valuation case for upside seekers. However, the forward P/E of 22.4 exceeds the industry average of 17.1, flagging relative overvaluation on a multiples basis. Volatility remains elevated at 49% over the past 30 days, and the maximum historical drawdown of 51% highlights the potential for sharp declines.
Fundamentally, HYBE posted a 39.5% revenue surge but continues to generate negative operating (‑28%) and profit margins (‑16%), with a negative ROE (‑13%). The balance sheet shows ample cash (1.89 trillion KRW) offset by high debt (984 billion KRW) and a debt‑to‑equity ratio of 27.3, raising concerns about leverage sustainability. Dividend yield is a modest 0.23% with a payout ratio of 15%, but ongoing losses make the dividend’s long‑term sustainability doubtful. Analysts are overwhelmingly positive (25 analysts, “strong_buy”) and target a median price of 383,000, yet the combination of high volatility, low beta, and a bearish technical backdrop suggests caution.
Fundamentally, HYBE posted a 39.5% revenue surge but continues to generate negative operating (‑28%) and profit margins (‑16%), with a negative ROE (‑13%). The balance sheet shows ample cash (1.89 trillion KRW) offset by high debt (984 billion KRW) and a debt‑to‑equity ratio of 27.3, raising concerns about leverage sustainability. Dividend yield is a modest 0.23% with a payout ratio of 15%, but ongoing losses make the dividend’s long‑term sustainability doubtful. Analysts are overwhelmingly positive (25 analysts, “strong_buy”) and target a median price of 383,000, yet the combination of high volatility, low beta, and a bearish technical backdrop suggests caution.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term SMAs indicating bearish bias
- Bullish MACD crossover suggesting limited upside
- High 30‑day volatility and recent drawdown risk
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value implies ~78% upside
- Strong analyst consensus with median target near 383k
- Revenue growth of 39.5% and diversification into IP and games
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Large cash reserves to fund strategic initiatives
- Potential to improve margins as new business lines mature
- Undervalued relative to DCF despite current earnings losses
Key Metrics & Analysis
Financial Health
Revenue Growth39.50%
Profit Margin-16.01%
P/E Ratio22.4
ROE-12.96%
ROA-1.88%
Debt/Equity27.28
Op. Cash Flow₩250.9B
Free Cash Flow₩471.1B
Industry P/E17.1
Technical Analysis
TrendBearish
RSI43.2
Support₩195,000.00
Resistance₩255,000.00
MA 20₩223,920.00
MA 50₩244,418.00
MA 200₩299,419.50
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71
Valuation
Fair Value₩416,047.32
Target Price₩389,920.00
Upside/Downside78.86%
GradeUndervalued
TypeBlend
Dividend Yield0.23%
Risk Assessment
Beta-0.06
Volatility49.31%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.